Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors-Reference-Cited by-同舟云学术

Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors

Published:2019-02-04 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Kovács Tünde,Mikó Edit,Vida András,Sebő Éva,Toth Judit,Csonka Tamás,Boratkó Anita,Ujlaki Gyula,Lente Gréta,Kovács Patrik,Tóth Dezső,Árkosy Péter,Kiss Borbála,Méhes Gábor,Goedert James J.,Bai Péter

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-37664-7.pdf

Reference69 articles.

1. Macfabe, D. Autism: metabolism, mitochondria, and the microbiome. Glob Adv Health Med 2, 52–66 (2013).

2. Maruvada, P., Leone, V., Kaplan, L. M. & Chang, E. B. The Human Microbiome and Obesity: Moving beyond Associations. Cell Host Microbe. 22, 589–599 (2017).

3. Fulbright, L. E., Ellermann, M. & Arthur, J. C. The microbiome and the hallmarks of cancer. PLoS Pathog. 13, e1006480 (2017).

4. Kundu, P., Blacher, E., Elinav, E. & Pettersson, S. Our Gut Microbiome: The Evolving Inner Self. Cell. 171, 1481–1493, https://doi.org/10.1016/j.cell.2017.1411.1024. (2017).

5. Zitvogel, L., Ayyoub, M., Routy, B. & Kroemer, G. Microbiome and Anticancer Immunosurveillance. Cell. 165, 276–287, https://doi.org/10.1016/j.cell.2016.1003.1001. (2016).

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacomicrobiomics in precision cancer therapy: bench to bedside;Frontiers in Immunology;2024-09-09

2. Microbiome—Stealth Regulator of Breast Homeostasis and Cancer Metastasis;Cancers;2024-08-31

3. TAAR8 Mediates Increased Migrasome Formation by Cadaverine in RPE Cells;Current Issues in Molecular Biology;2024-08-07

4. Elucidating the Intricate Roles of Gut and Breast Microbiomes in Breast Cancer Metastasis to the Bone;Cancer Reports;2024-08

5. Cytostatic Bacterial Metabolites Interfere with 5-Fluorouracil, Doxorubicin and Paclitaxel Efficiency in 4T1 Breast Cancer Cells;Molecules;2024-06-27